Nn9535-4801
Research payments
$4,329,996
Through program year 2025, $4,329,996 in research payments was reported against Nn9535-4801, across 24,271 payments.
- Paid by (largest first)
- Novo Nordisk AS; Novo Nordisk Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $658,829 | 300 |
| 2024 | Research | $1,667,006 | 8,836 |
| 2023 | Research | $1,701,103 | 8,026 |
| 2022 | Research | $303,057 | 7,109 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Neil Fraser Troy, MI Named on 1,156 payments
- Danny Sugimoto Chicago, IL Named on 713 payments
- David Fittingoff West Hills, CA Named on 681 payments
- David Doriguzzi Lancaster, CA Named on 623 payments
- Blair Brengle Indianapolis, IN Named on 609 payments
- Michelle Welch Shavano Park, TX Named on 608 payments
- J. Evans Jacksonville, FL Named on 549 payments
- Rickey Manning Knoxville, TN Named on 541 payments
- Steve Fordan Dallas, TX Named on 530 payments
- Osama Hamdy Boston, MA Named on 496 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.